C. R. Bard
Clinical trials sponsored by C. R. Bard, explained in plain language.
Medical device company, acquired by BD, known for vascular and urology products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a less invasive catheter replace the tube in intensive care? Results expected Oct 2026 (estimated)
- New balloon could help dialysis patients avoid repeat procedures Results expected Apr 2027 (estimated)
- New device aims to simplify dialysis access for kidney patients Results expected Jun 2027 (estimated)
-
New device aims to simplify dialysis access for kidney patients
Disease control Recruiting nowThis study is testing a device called the WavelinQ EndoAVF System that creates a connection between an artery and a vein (AV fistula) in people who need dialysis. The goal is to make it easier to start and continue dialysis with fewer complications. About 280 adults with end-stag…
Sponsor: C. R. Bard • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New mesh aims to stop painful breast implant scarring
Disease control Recruiting nowThis study tests a special mesh called GalaFLEX LITE™ in women who need surgery for painful scar tissue (capsular contracture) around breast implants. About 250 women will be randomly assigned to get either the mesh or standard surgery alone. The goal is to see if the mesh helps …
Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New liver stent aims to tame deadly cirrhosis complications
Disease control Recruiting nowThis study tests a special stent called LIVERTY TIPS, placed in the liver to create a new pathway for blood flow in people with cirrhosis and high blood pressure in the liver. The goal is to see if it can keep the new channel open and reduce problems like bleeding or fluid buildu…
Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New rotating catheter aims to unclog leg arteries without major surgery
Disease control Recruiting nowThis study is tracking 600 people with peripheral artery disease (PAD) who are treated with the Rotarex device, a rotating catheter that cuts and removes plaque from blocked leg arteries. The goal is to see how well the device restores blood flow and how often serious complicatio…
Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC